DSG, Inc. and OVATION Pharmaceuticals, Inc. Partner in Several Phase I Studies

MALVERN, Pa.--(BUSINESS WIRE)--DSG, Inc., a leading EDC and clinical software technology provider, today announced that OVATION Pharmaceuticals, Inc. (OVATION) is using DSG’s award-winning eCaseLink EDC software to conduct several Phase I clinical trials. DSG is one of OVATION’s preferred providers for EDC software for these studies.
MORE ON THIS TOPIC